A 16-year-old female with persistent lower extremity lesions and community-acquired methicillin-resistant Staphylococcus aureus

Pediatric Emergency Care

Volumn 21, Issue 2, 2005, Pages 134-136

  Mirkinson, Laura J ^a  

^a HOLY CROSS HOSPITAL   (United States)

Author keywords

Methicillin resistant; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; OXACILLIN; PSEUDOMONIC ACID; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CASE REPORT; CHILD HOSPITALIZATION; CLINICAL FEATURE; COMMUNICABLE DISEASE; DISEASE COURSE; DRUG RESPONSE; ERYTHEMA; FEMALE; HUMAN; LYMPHADENOPATHY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PHYSICAL EXAMINATION; PUS; PUSTULE; SYMPTOM;

ADOLESCENT; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; LEG; METHICILLIN RESISTANCE; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS;

EID: 13844264397     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pec.0000159061.80177.cc     Document Type: Article

References (16)

1. NNIS National Nosocomial Infections Surveillance ICU Report December 1999. CDC, Division of Healthcare Quality Promotion. Available at: http://www.cdc.gov/ncidod/hip/NNIS/av_surv99.htm.
2. CDC. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control. 2003;31:481-498.
3. Jevons MP. 'Celbenin'-resistant staphylococci. Br Med J. 1961;1:124-125.
4. Hiramatsu K, Cui L, Kuroda M, et al. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbial. October 2001;9(10):486-493.
5. VandenBergh MRA, Yzerman EPF, van Belkum A, et al. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol October 1999;37(10):3133-3140.
6. Eady EA, Cove JH. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus-An emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis. April 2003;16(2):103-124.
7. Dietrich DW, Auld DB, Mermel LA. Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children. Pediatrics. April 2004;113(4):e347-e352.
8. Naimi S, LeDell KH, Boxrud DJ, et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis. 2001;33:990-996.
9. Jerniganm JA, Pullen AL, Partin C, et al. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus in an outpatient clinic population. Infect Control Hosp Epidemiol. 2003;24:445-450.
10. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. February 25, 1998;259(8):593-598.
11. Eady EA, Cove JH. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus-An emerging problem for the management of skin and soft tissue infections. Curr Opin infect Dis. April 2003;16(2):103-124.
12. Tenover FC, Biddle JW, Lancaster MV. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis (CDC). March-April 2001;7(2):327-332.
13. Fridkin SK. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis. 2001;32:108-115.
14. Siberry GK, Tekle T, Carroll K, et al. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis. November 2003;37:1257-1260.
15. Linoncou MH, Ermertcan S, Cetin CB, et al. Emergence of phenotypic resistance to ciprofloxacin and levofloxacin in methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains. Int J Antimicrob Agents. May 2003;21(5):420-424.
16. Whitener CJ, Park SY, Browne FA, et al. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis. 2004;38:1049-1055.